Contextualising sustainable infrastructure development in Nigeria

The clamour for sustainability in all spheres of development is more in the developed economies but the responsibility is no less for the developing economies. Efforts targeted at sustaining infrastructural development in Nigeria are deficient in context and formalisation. This paper therefore contributes to the efforts at formalising and contextualising sustainable infrastructural development in Nigeria. The paper relied on literature review for textual data in support of sustainable infrastructural development. The findings reveal the state of infrastructure development and approaches that are strategic to the development of sustainable infrastructure in Nigeria. The suggested approaches grinded on global best practice and made to reflect the peculiarity of the contemporary Nigerian environment. The paper advocates for a more committed government effort and an inclusive civil society participation in sustainable infrastructure development in Nigeria.Keywords: Sustainability, Infrastructure, Development, Construction Industry, Nigeri

Safety, Efficacy and Tolerability of Meprasilm in the Treatment of Dyspepsia among Nigerians.

A clinical trial was carried out to establish the tolerability, safety and efficacy of Meprasil brand of omeprazole among Nigerians with acid peptic disease using 20mg daily or 20mg bid of Meprasil. Forty patients were enrolled for the study and were asked to rate their abdominal pains pre-commencement of therapy using a scale of mild, moderate or severe. Serum alanine transaminase (ALT), urinalysis, electrolytes, creatinine and urea were carried out before and after treatment. Patients were then evaluated on days 0, 1, 3, 7, 14, and 28, thereafter monthly for 4 months for relief of symptoms and adverse drugs effect. Only 32 patients completed the study, 17 (Group I) and 15 (Group II).fe, efficacious and well tolerated in amelioration of pain of acid peptic disorder among Nigerian patients

Safety, efficacy and tolerability of meprasilm in the treatment of dyspepsia among nigerians.

A clinical trial was carried out to establish the tolerability, safety and efficacy of Meprasil brand of omeprazole among Nigerians with acid peptic disease using 20mg daily or 20mg bid of Meprasil. Forty patients were enrolled for the study and were asked to rate their abdominal pains pre-commencement of therapy using a scale of mild, moderate or severe. Serum alanine transaminase (ALT), urinalysis, electrolytes, creatinine and urea were carried out before and after treatment. Patients were then evaluated on days 0, 1, 3, 7, 14, and 28, thereafter monthly for 4 months for relief of symptoms and adverse drugs effect. Only 32 patients completed the study, 17 (Group I) and 15 (Group II).fe, efficacious and well tolerated in amelioration of pain of acid peptic disorder among Nigerian patients